PEN:NYSE
Penumbra Inc
US$ ३१९.१२
arrow_downward
-०.२८%(-०.८९) 1D
US$ ३१९.१२
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०३ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
US$ ३१९.९१
High
US$ ३२०.३२
Low
US$ ३१९.०२
Mkt. cap
१२.५८ अरब
Avg. vol.
३.६३ लाख
Volume
२.०५ लाख
P/E ratio
८०.३४
52-wk high
US$ ३६२.४१
52-wk low
US$ २७९.६९
EPS
US$ ३.९७
Beta
०.७१
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
Open
US$ ३१९.९१
High
US$ ३२०.३२
Low
US$ ३१९.०२
Mkt. cap
१२.५८ अरब
Avg. vol.
३.६३ लाख
Volume
२.०५ लाख
P/E ratio
८०.३४
52-wk high
US$ ३६२.४१
52-wk low
US$ २७९.६९
EPS
US$ ३.९७
Beta
०.७१
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
News stories
From web sources and news partners
Investing.com UK
·
२ दिन पहिले
Form 424B5 Penumbra Inc For: 19 November By Investing.com
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc
CEOAdam Elsesser
Employees४.७ हजार
Founded२००४
Headquarters-
SectorHealth Care
Industry-
Websitepenumbrainc.com